$3.63
-0.17-4.47%
At Close: -
$3.70
0.071.93%
After Hours: 9:25 AM EDT
15 minutes delayed
ProPhase Labs
PRPHNASDAQ
ProPhase Labs (PRPH) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestProPhase Labs (NASDAQ:PRPH) Stock Quotes, Forecast and News Summary
ProPhase Labs Stock (NASDAQ: PRPH) stock price, news, charts, stock research, profile.
| Open | $3.65 |
| Close | $3.63 |
| Volume / Avg. | 28.99K / 59.53K |
| Day Range | 3.56 - 3.70 |
| 52 Wk Range | 3.80 - 7.59 |
| Market Cap | $69.26M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 22 |
| Short Interest | 2.01% |
| Days to Cover | 12.23 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About ProPhase Labs Inc
Sector
Health Care
Industry
Pharmaceuticals
ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic test...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy ProPhase Labs (PRPH) stock?
You can purchase shares of ProPhase Labs (NASDAQ:PRPH) through any online brokerage.
Who are ProPhase Labs (PRPH) competitors?
Other companies in ProPhase Labs’s space includes: SCYNEXIS (NASDAQ:SCYX), CalciMedica (NASDAQ:CALC), Ocuphire Pharma (NASDAQ:OCUP), Rani Therapeutics Hldgs (NASDAQ:RANI) and Lipocine (NASDAQ:LPCN).
What is the target price for ProPhase Labs (PRPH) stock?
There is no analysis for ProPhase Labs.
What is the forecast for ProPhase Labs (PRPH) stock?
ProPhase Labs has a consensus price target of $5.50.
Current stock price for ProPhase Labs (PRPH)?
The stock price for ProPhase Labs (NASDAQ: PRPH) is $3.63 last updated July 3, 2024 at 1:00 PM EDT.
Does ProPhase Labs (PRPH) pay a dividend?
A quarterly cash dividend of 0.30 per share of Class A Common Stock. The quarterly cash dividend was payable on June 3, 2022 to stockholders of record on May 24, 2022.
When is ProPhase Labs (NASDAQ:PRPH) reporting earnings?
ProPhase Labs’s Q2 earnings are confirmed for Thursday, August 8, 2024.
Is ProPhase Labs (PRPH) going to split?
There is no upcoming split for ProPhase Labs.
What sector and industry does ProPhase Labs (PRPH) operate in?
ProPhase Labs is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.